Simply Good Foods forecasts fiscal 2027 net sales decline of 13%–17%
Bitget2026/10/27 12:08- Simply Good Foods forecasts fiscal 2027 net sales declining 13%-17%; adjusted EBITDA is expected to fall 9%-14%.
- First-quarter fiscal 2027 net sales are projected to fall 19%-22%; adjusted EBITDA is forecast to decline 28%-33%.
- Full-year gross margin is expected to expand 250-300 basis points, supported by pricing, productivity initiatives and lower one-time costs.
- Second-half performance is expected to improve materially from the first half, with some margin recovery reinvested in marketing.
- The outlook reflects consumption trends, pricing effects and distribution losses; fourth-quarter fiscal 2026 net sales fell 9.7% to $333.3 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Trump Media & Technology Group plunges over 24%, hitting a new low since listing.
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.